Using CQC Quality Statements to Evidence Safe Medicines Management and Clinical Oversight

Safe medicines management is one of the most scrutinised areas under CQC quality statements, requiring providers to evidence not just compliance, but consistent, safe and accountable practice. Errors, omissions or poor recording can quickly escalate into safeguarding concerns or regulatory action. This is particularly important from the point of CQC registration, where providers must demonstrate robust systems for medicines governance, staff competence and clinical oversight. The strongest services are those where medicines processes are embedded into daily routines and supported by clear leadership assurance.

This topic forms part of a wider compliance framework that includes registration, inspection and quality assurance expectations. You can explore these in our CQC registration and quality assurance knowledge hub for adult social care.

Embedding medicines safety into daily practice

Medicines management should not be treated as a discrete task but as part of a wider safety system. This includes storage, administration, recording, review and escalation. Staff must understand the importance of accuracy, timing and observation, as well as the risks associated with missed or incorrect doses.

Providers should ensure that medicines protocols are practical, clearly understood and consistently applied. This includes clear guidance on controlled drugs, PRN medicines and covert administration, as well as escalation pathways for errors or concerns.

Moving from compliance to competence

Training alone is not sufficient to demonstrate safe medicines practice. Providers must evidence that staff are competent, confident and able to apply procedures correctly in real situations. This requires observation, supervision and regular competency assessments.

Managers should be able to demonstrate that staff understand why procedures are in place, not just how to follow them. This supports safer decision-making and reduces the risk of error.

Operational example 1: addressing missed medicines and strengthening systems

Context: A routine audit identifies that a morning dose of medication was missed due to a delay in staff arrival. No immediate harm occurred, but the incident highlights a system weakness.

Support approach: The provider reviews staffing patterns, handover arrangements and contingency planning to ensure medicines can be administered safely even during unexpected delays.

Day-to-day delivery detail: Staff are instructed to escalate delays immediately, with senior staff or on-call managers providing cover where required. Handovers include medicines priorities, and rotas are reviewed to ensure adequate coverage at key times.

How effectiveness is evidenced: Evidence includes improved audit results, reduced missed doses, clearer escalation records and staff understanding of contingency processes.

Operational example 2: improving PRN medicines recording and oversight

Context: Staff administer PRN medication for pain relief, but recording lacks detail on rationale and effectiveness.

Support approach: The provider introduces clearer guidance on PRN protocols, including the need to document reasons for administration and outcomes.

Day-to-day delivery detail: Staff record the person’s presentation, the reason for administration, the dose given and the observed effect. Managers review PRN usage regularly to identify patterns or concerns.

How effectiveness is evidenced: Evidence includes improved recording, clearer audit trails, better understanding of PRN use and more informed clinical reviews.

Operational example 3: strengthening controlled drugs governance

Context: A discrepancy is identified in the controlled drugs register, raising concerns about accuracy and oversight.

Support approach: The provider conducts an immediate investigation, reviews procedures and reinforces staff training on controlled drugs management.

Day-to-day delivery detail: Controlled drugs are checked at each shift change, with dual signatures required. Managers conduct regular audits and spot checks, and discrepancies are escalated immediately.

How effectiveness is evidenced: Evidence includes accurate registers, consistent staff practice, audit compliance and clear documentation of investigations and outcomes.

Commissioner expectation

Commissioner expectation: Commissioners expect providers to demonstrate that medicines management is safe, reliable and consistently applied. This includes evidence of staff competence, effective governance and timely response to errors or concerns.

Regulator / Inspector expectation

Regulator / Inspector expectation: CQC will expect providers to show that medicines are managed safely, with clear records, competent staff and robust oversight. Inspectors will look for alignment between procedures, practice and outcomes.

Governance and clinical oversight

Strong medicines management requires clear governance systems. This includes regular audits, competency assessments, incident reviews and management oversight. Providers should also analyse trends, such as recurring errors or high PRN usage, to identify areas for improvement.

Leadership oversight should ensure that medicines management remains a priority, with clear accountability and regular review. This approach supports continuous improvement and strengthens assurance.

When medicines management is embedded into quality statements, it becomes a reliable indicator of service safety and effectiveness, providing confidence for regulators, commissioners and people using services.

---